The Institute of Oncology, Arensia Exploratory Medicine
Chisinau 2025
2 studies enrolling now · 5 studies all time
What they study most
Advanced Breast Cancer, Advanced Solid Tumor, B-cell Malignancy, Bladder Cancer, Breast Cancer, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Follicular Lymphoma, Gastric Cancer, GastroEsophageal Cancer, HER2-negative Breast Cancer
Studies at this site
- A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
- BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors — Recruiting now
- An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
- A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors — Running, not enrolling
- A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer — Running, not enrolling